By The Online Investor Staff, updated Fri., Feb. 12, 9:22 PM
Slide #1. Proteostasis Therapeutics, Inc. — Initial Public Offering
||Proteostasis Therapeutics, Inc.
|Price Per Share:
||Proteostasis Therapeutics, Inc. today announced the pricing of its initial public offering of 6,250,000 shares of common stock at a public offering price of $8.00 per share, before underwriting discounts and commissions. All of the common stock is being offered by Proteostasis Therapeutics, Inc. In addition, the company has granted the underwriters a 30-day option to purchase up to an additional 937,500 shares of common stock from the company at the public offering price. The company's shares are expected to begin trading on the NASDAQ Global Market on February 11, 2016 under the ticker symbol "PTI." The offering is expected to close on February 17, 2016 subject to customary closing conditions.
IPOs: Proteostasis Therapeutics, Inc.
List of IPOs in this Slideshow:
Company Ticker IPO Date
Mesoblast Limited MESO
Mimecast Limited MIME
Match Group, Inc. MTCH
Square, Inc. SQ
Duluth Holdings Inc. DLTH
Kitov Pharmaceuticals Holdings Ltd. KTOV
Yirendai Ltd. YRD
China Customer Relations Centers, Inc. CCRC
Advanced Disposal Services, Inc. ADSW
BeiGene, Ltd. BGNE
Editas Medicine, Inc. EDIT
AveXis, Inc. AVXS
Proteostasis Therapeutics, Inc. PTI
February 12, 2016 9:22 PM Eastern